Hauptseite > Publikationsdatenbank > 11C- and 18F-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders > print

001     878350
005     20210130005555.0
024 7 _ |a 10.1070/RCR4954
|2 doi
024 7 _ |a 0036-021X
|2 ISSN
024 7 _ |a 1468-4837
|2 ISSN
024 7 _ |a 2128/25477
|2 Handle
024 7 _ |a WOS:000557617800001
|2 WOS
037 _ _ |a FZJ-2020-02797
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Zlatopolskiy, B. D.
|0 P:(DE-HGF)0
|b 0
245 _ _ |a 11C- and 18F-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders
260 _ _ |a [Letchworth]
|c 2020
|b Turpion
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1597156273_26594
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The ageing of the world's population is the result of increased life expectancy observed in almost all countries throughout the world. Consequently, a rising tide of ageing-associated disorders, like cancer and neurodegenerative diseases, represents oneof the main global challenges of the 21st century. The ability of mankind to overcome these challenges is directly dependent on the capability to develop novel methods for therapy and diagnosis of age-associated diseases. One hallmark of age-relatedpathologies is an altered tryptophan metabolism. Numerous pathological processes including neurodegenerative and neurological diseases like epilepsy, Parkinson's and Alzheimer's diseases, cancer and diabetes exhibit marked changes intryptophan metabolism. Visualization of key processes of tryptophan metabolic pathways, especially using positron emission tomography (PET) and related hybrid methods like PET/CT and PET/MRI, can be exploited to early detect theaforementioned disorders with considerable accuracy, allowing appropriate and timely treatment of patients. Here we review the published 11C- and 18F-labelled tryptophans with respect to the production and also preclinical and clinical evaluation asPET-tracers for visualization of different branches of tryptophan metabolism.The bibliography includes 159 references.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Endepols, H.
|0 P:(DE-Juel1)180330
|b 1
|u fzj
700 1 _ |a Krasikova, R. N.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Fedorova, O. S.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Ermert, J.
|0 P:(DE-Juel1)131818
|b 4
|u fzj
700 1 _ |a Neumaier, B.
|0 P:(DE-Juel1)166419
|b 5
|e Corresponding author
|u fzj
773 _ _ |a 10.1070/RCR4954
|g Vol. 89, no. 9, p. 879 - 896
|0 PERI:(DE-600)1474827-7
|n 9
|p 879 - 896
|t Russian chemical reviews
|v 89
|y 2020
|x 1468-4837
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/878350/files/Imaging%20of%20altered%20tryptophan%20metabolism_final%20version.pdf
856 4 _ |y Restricted
|u https://juser.fz-juelich.de/record/878350/files/Zlatopolskiy_2020_Russ._Chem._Rev._89_879.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/878350/files/Imaging%20of%20altered%20tryptophan%20metabolism_final%20version.pdf?subformat=pdfa
856 4 _ |y Restricted
|x pdfa
|u https://juser.fz-juelich.de/record/878350/files/Zlatopolskiy_2020_Russ._Chem._Rev._89_879.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:878350
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)180330
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131818
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2020-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-03
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-01-03
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-01-03
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b RUSS CHEM REV+ : 2018
|d 2020-01-03
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2020-01-03
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-03
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-01-03
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-03
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21